Lepodisiran and the Emerging Role of Oxidized Phospholipids in Lipoprotein(a) Risk

Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals by Cleveland Clinic Heart & Vascular Institute

Luke Laffin, MD, speaks with Steven Nissen, MD, about findings from the ALPACA trial evaluating lepodisiran and its effects on oxidized phospholipids and lipoprotein(a). They discuss the potential mechanisms linking lipo...View more